Cross Country Healthcare, Inc. (CCRN)
USD 14.21
(-0.42%)
USD 14.21
(-0.42%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | - USD | -100.0% |
| 2022 | 11.06 Million USD | 44.7% |
| 2021 | 7.64 Million USD | 40.2% |
| 2020 | 5.45 Million USD | -10.53% |
| 2019 | 6.09 Million USD | -1.79% |
| 2018 | 6.2 Million USD | 17.42% |
| 2017 | 5.28 Million USD | -13.7% |
| 2016 | 6.12 Million USD | 35.5% |
| 2015 | 4.52 Million USD | -25.56% |
| 2014 | 6.07 Million USD | -1.46% |
| 2013 | 6.16 Million USD | -90.53% |
| 2012 | 65.11 Million USD | 260.01% |
| 2011 | 18.08 Million USD | 53.26% |
| 2010 | 11.8 Million USD | 269.47% |
| 2009 | 3.19 Million USD | -89.43% |
| 2008 | 30.21 Million USD | 42.81% |
| 2007 | 21.15 Million USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 4.68 Million USD | -44.18% |
| 2001 | 8.39 Million USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.00 USD | 0.0% |
| 2024 Q2 | 1.00 USD | 0.0% |
| 2023 FY | - USD | -100.0% |
| 2023 Q3 | 4.77 Million USD | -29.23% |
| 2023 Q1 | 10.93 Million USD | -1.17% |
| 2023 Q4 | - USD | -100.0% |
| 2023 Q2 | 6.75 Million USD | -38.26% |
| 2022 Q1 | 7.68 Million USD | 0.54% |
| 2022 Q2 | 1.00 USD | -100.0% |
| 2022 FY | 11.06 Million USD | 44.7% |
| 2022 Q4 | 11.06 Million USD | 180.04% |
| 2022 Q3 | 3.95 Million USD | 395199900.0% |
| 2021 Q4 | 7.64 Million USD | 123.76% |
| 2021 Q3 | 3.41 Million USD | -34.05% |
| 2021 Q2 | 5.18 Million USD | -4.55% |
| 2021 FY | 7.64 Million USD | 40.2% |
| 2021 Q1 | 5.43 Million USD | -0.46% |
| 2020 Q3 | 3.34 Million USD | -36.53% |
| 2020 Q4 | 5.45 Million USD | 62.93% |
| 2020 FY | 5.45 Million USD | -10.53% |
| 2020 Q1 | 6.37 Million USD | 4.54% |
| 2020 Q2 | 5.27 Million USD | -17.24% |
| 2019 Q1 | 4.84 Million USD | -21.97% |
| 2019 Q2 | 5.7 Million USD | 17.8% |
| 2019 Q4 | 6.09 Million USD | 61.98% |
| 2019 Q3 | 3.76 Million USD | -34.03% |
| 2019 FY | 6.09 Million USD | -1.79% |
| 2018 FY | 6.2 Million USD | 17.42% |
| 2018 Q4 | 6.2 Million USD | 5.76% |
| 2018 Q3 | 5.87 Million USD | -8.75% |
| 2018 Q2 | 6.43 Million USD | 4.72% |
| 2018 Q1 | 6.14 Million USD | 16.19% |
| 2017 FY | 5.28 Million USD | -13.7% |
| 2017 Q4 | 5.28 Million USD | 2.82% |
| 2017 Q3 | 5.14 Million USD | -17.46% |
| 2017 Q2 | 6.23 Million USD | 8.78% |
| 2017 Q1 | 5.72 Million USD | -6.51% |
| 2016 Q3 | 5.27 Million USD | 3.96% |
| 2016 Q2 | 5.07 Million USD | 3.85% |
| 2016 FY | 6.12 Million USD | 35.5% |
| 2016 Q4 | 6.12 Million USD | 16.22% |
| 2016 Q1 | 4.88 Million USD | 7.98% |
| 2015 Q4 | 4.52 Million USD | -6.14% |
| 2015 Q2 | 6.69 Million USD | 14.24% |
| 2015 FY | 4.52 Million USD | -25.56% |
| 2015 Q3 | 4.81 Million USD | -28.07% |
| 2015 Q1 | 5.86 Million USD | -3.47% |
| 2014 Q2 | 7.75 Million USD | 21.33% |
| 2014 Q1 | 6.38 Million USD | 3.67% |
| 2014 Q3 | 8.38 Million USD | 8.17% |
| 2014 Q4 | 6.07 Million USD | -27.57% |
| 2014 FY | 6.07 Million USD | -1.46% |
| 2013 Q3 | 19.51 Million USD | -0.18% |
| 2013 Q2 | 19.54 Million USD | -0.81% |
| 2013 Q1 | 19.7 Million USD | -69.74% |
| 2013 FY | 6.16 Million USD | -90.53% |
| 2013 Q4 | 6.16 Million USD | -68.41% |
| 2012 Q1 | 18.36 Million USD | 1.54% |
| 2012 FY | 65.11 Million USD | 260.01% |
| 2012 Q2 | 18.25 Million USD | -0.59% |
| 2012 Q4 | 65.11 Million USD | 245.83% |
| 2012 Q3 | 18.82 Million USD | 3.13% |
| 2011 Q4 | 18.08 Million USD | -7.39% |
| 2011 Q1 | 19.02 Million USD | 3.76% |
| 2011 Q3 | 19.52 Million USD | 3.3% |
| 2011 Q2 | 18.9 Million USD | -0.61% |
| 2011 FY | 18.08 Million USD | 53.26% |
| 2010 Q1 | -901 Thousand USD | -108.08% |
| 2010 FY | 11.8 Million USD | 269.47% |
| 2010 Q3 | 3.8 Million USD | 63.7% |
| 2010 Q4 | 18.33 Million USD | 382.27% |
| 2010 Q2 | 2.32 Million USD | 357.71% |
| 2009 Q3 | 11.91 Million USD | -29.14% |
| 2009 FY | 3.19 Million USD | -89.43% |
| 2009 Q4 | 11.14 Million USD | -6.42% |
| 2009 Q2 | 16.81 Million USD | 1.37% |
| 2009 Q1 | 16.58 Million USD | -45.11% |
| 2008 Q4 | 30.21 Million USD | 163.35% |
| 2008 Q2 | 6.53 Million USD | 4.1% |
| 2008 Q1 | 6.27 Million USD | -70.34% |
| 2008 FY | 30.21 Million USD | 42.81% |
| 2008 Q3 | 11.47 Million USD | 75.65% |
| 2007 FY | 21.15 Million USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q4 | 21.15 Million USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | -100.0% |
| 2006 Q2 | 6.7 Million USD | -11.77% |
| 2006 Q1 | 7.59 Million USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 Q1 | - USD | -100.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 FY | - USD | -100.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2002 FY | 4.68 Million USD | -44.18% |
| 2002 Q4 | 4.68 Million USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q1 | - USD | -100.0% |
| 2002 Q2 | - USD | 0.0% |
| 2001 Q4 | 8.39 Million USD | 0.0% |
| 2001 FY | 8.39 Million USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |